Leishmaniasis Reactivation
What is Leishmaniasis Reactivation?
Leishmaniasis reactivation occurs when a previously treated or dormant leishmania infection becomes active again. Leishmania are parasites spread by infected sandfly bites. After initial infection and treatment, the parasites can remain dormant in your body for years.
When your immune system becomes weakened, these dormant parasites can reactivate and cause symptoms again. This reactivation can happen months or even decades after the original infection. People who have traveled to or lived in areas where leishmaniasis is common face this risk.
Reactivation most often affects people with weakened immune systems from HIV, cancer treatments, or medications that suppress immunity. Understanding your risk factors helps you and your doctor watch for early signs of reactivation.
Symptoms
- Fever that comes and goes over weeks or months
- Unexplained weight loss and loss of appetite
- Extreme tiredness and weakness
- Enlarged spleen or liver that may cause abdominal discomfort
- Skin sores or lesions, especially around the face and extremities
- Persistent cough or difficulty breathing in severe cases
- Night sweats and chills
- Pale skin or anemia symptoms
- Easy bruising or bleeding
Some people with early reactivation may have very mild symptoms that are easy to miss. Symptoms often develop slowly over weeks to months, making early detection challenging.
Concerned about Leishmaniasis Reactivation? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Leishmaniasis reactivation happens when your immune system cannot keep dormant parasites under control. The most common trigger is immunosuppression from HIV or AIDS, which weakens the immune cells that normally suppress the parasites. Cancer treatments like chemotherapy also reduce immune function and allow reactivation. Medications that suppress immunity, such as those used after organ transplants or for autoimmune diseases, create similar risks.
Other risk factors include severe malnutrition, advanced age, and certain chronic diseases that affect immune function. People with a history of visceral leishmaniasis, the most serious form of the disease, face higher reactivation risk. Geographic factors matter too, as the original infection typically occurred in regions where sandflies carrying leishmania are common, including parts of South America, the Mediterranean, Africa, and Asia.
How it's diagnosed
Doctors diagnose leishmaniasis reactivation through a combination of your medical history, physical exam, and specialized laboratory tests. Your doctor will ask about past infections, travel history, and current immune status. Blood tests can measure antibody levels against leishmania parasites using tests like Leishmania Ab IgG. High antibody levels in someone with a history of leishmaniasis may suggest reactivation, especially if you have immunosuppression.
Additional testing often includes microscopic examination of tissue samples from bone marrow, spleen, or skin lesions to look for parasites directly. PCR testing can detect parasite DNA with high sensitivity. Complete blood counts may show anemia, low white blood cells, or low platelets. Talk to your doctor about specialized testing if you have a history of leishmaniasis and develop new symptoms or start immunosuppressive treatments.
Treatment options
- Antiparasitic medications such as liposomal amphotericin B or miltefosine to eliminate active parasites
- Managing the underlying cause of immunosuppression when possible
- Adjusting immunosuppressive medications if medically safe to do so
- Nutritional support to address malnutrition and support immune function
- Antiretroviral therapy for HIV-positive patients to restore immune function
- Regular monitoring with blood tests to track treatment response
- Preventive therapy in some high-risk patients to reduce reactivation risk
- Working closely with infectious disease specialists for treatment planning
Frequently asked questions
Reactivation occurs when your immune system becomes too weak to control dormant parasites in your body. Common triggers include HIV infection, cancer chemotherapy, or medications that suppress immunity. The parasites can remain dormant for decades before reactivating when immune defenses drop.
The timing varies widely from person to person and depends on the degree of immunosuppression. Some people experience reactivation within months of starting immunosuppressive therapy. Others may not have symptoms for years, even with weakened immunity.
Prevention focuses on maintaining immune health and monitoring for early signs. If you need immunosuppressive treatment, your doctor may prescribe preventive antiparasitic medications. Regular blood tests can help detect reactivation early when treatment is most effective.
Leishmania antibody tests, specifically IgG antibodies, can indicate reactivation when levels are high in someone with past infection. Complete blood counts may show anemia or low blood cell counts. PCR tests that detect parasite DNA provide the most sensitive detection of active infection.
No, you cannot spread leishmaniasis directly to other people through casual contact. The parasites require sandfly bites to transmit between hosts. However, blood transfusions or organ transplants from infected individuals can rarely transmit the parasites.
Reactivation involves parasites that have been dormant in your body since a previous infection becoming active again. A new infection requires a fresh sandfly bite from an infected insect. Reactivation typically occurs in people with weakened immune systems, while new infections can affect anyone exposed to infected sandflies.
Untreated reactivation can progress to severe visceral leishmaniasis affecting your liver, spleen, and bone marrow. This can lead to life-threatening complications including severe anemia, bleeding problems, and overwhelming infections. Early treatment greatly improves outcomes and reduces the risk of serious complications.
Yes, if you have both HIV and a history of leishmaniasis, regular monitoring is important. Your doctor should check for signs of reactivation periodically, especially if your CD4 count drops. Starting antiretroviral therapy helps restore immune function and reduces reactivation risk significantly.
Maintaining overall health supports immune function but may not prevent reactivation if you need immunosuppressive treatments. Good nutrition, adequate sleep, and stress management support your immune system. The most important step is working with your doctor to monitor your condition and start treatment early if needed.
Treatment duration depends on the severity of reactivation and your immune status. Most people receive antiparasitic medications for several weeks. Those with ongoing immunosuppression may need longer treatment courses or maintenance therapy to prevent recurrence after initial treatment.